Cargando…
Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial
More sensitive biomarker is urgently needed to reduce the mortality caused by the worldwide prevalent liver cancer. This study aims to assess whether quantitative measurement of heat shock protein 90alpha (Hsp90α) in plasma can improve the diagnosis accuracy and monitor treatment response of liver c...
Autores principales: | Fu, Yan, Xu, Xiao, Huang, Dongsheng, Cui, Dawei, Liu, Lisheng, Liu, Junwei, He, Zenglei, Liu, Jingjing, Zheng, Shusen, Luo, Yongzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652007/ https://www.ncbi.nlm.nih.gov/pubmed/28939487 http://dx.doi.org/10.1016/j.ebiom.2017.09.007 |
Ejemplares similares
-
A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
por: Liu, Wei, et al.
Publicado: (2019) -
Extracellular Heat Shock Protein-90 (eHsp90): Everything You Need to Know
por: Jay, Daniel, et al.
Publicado: (2022) -
Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development
por: Wei, Wene, et al.
Publicado: (2021) -
Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma
por: Zhao, Qiang, et al.
Publicado: (2021) -
Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics
por: Han, Yueting, et al.
Publicado: (2021)